Loading...
Images of David Ladkani
(0 from 0 )Network Profiles
LinkedIn: David Ladkani, PhD - Expert in drug development - Self ...il.linkedin.com › david-ladkani-phd-9382b290
David Ladkani, PhD - Expert in drug development - Self employed | LinkedIn. Join nowSign in. David Ladkani, PhD.
LinkedIn: David Ladkani | LinkedIn
David Ladkanis berufliches Profil anzeigen LinkedIn ist das weltweit größte professionelle Netzwerk, das Fach- und Führungskräften wie David Ladkani dabei hilft, Kontakte zu finden, die mit empfohlenen Kandidaten, Branchenexperten und potenziellen Geschäftspartnern verbunden sind.
LinkedIn: David Ladkani | LinkedIn
View David Ladkani's (Israel) professional profile on LinkedIn. LinkedIn is the world's largest business network, helping professionals like David Ladkani ...
James Potts | AceMap
acemap.openacademic.ai
Herbert R Henney, Andrew R Blight, John S Grundy, Merit E Cudkowicz, Timothy Vollmer, Massimo Filippi, Enrique J Carrazana, Gary R Cutter, Richard T Penson, Ron Cohen, Chris Gerada, Susana M Campos, Arlan F Fuller, Peter L Choyke, David Ladkani. Content Based: Link: Andrew D Goodman. Co-author Map More.
Interests
David Ladkani - Patents
www.freshpatents.com
David Ladkani patents Recent bibliographic sampling of David Ladkani patents listed/published in the public domain by the USPTO (USPTO Patent Application #,Title):
Property
US Treatment Of Neurodegenerative Diseases With...
patentscope.wipo.int
This patent search tool allows you not only to search the PCT database of about 2 million International Applications but also the worldwide patent collections....
Books & Literature
Official Gazette of the United States Patent and Trademark ...books.google.com › books
books.google.de
... Shmuel Edelstein, Rehovot; Zeer Mazor, French Hill; David Ladkani, Kiryat Yovel; Benjamin Shalita, Ramat Hagolan, all of Israel, and John A. Kanis, Sheffield, ...
Related Documents
BioLineRx Ltd. - corporate-ir.net
services.corporate-ir.net
David Ladkani, M.D.. Dr. Ladkani has held roles of increasing responsibility in R&D, business development and medical affairs at senior levels for 35 years at Teva. His most recent position at Teva has been Vice President. Research, Scientific Affairs. Dr. Ladkani is the recipient of the Rothschild Award for ...
The glatiramoid class of immunomodulator drugs - [PDF Document]
fdocuments.us
Review © Informa UK Ltd ISSN All rights reserved: reproduction in whole or in part not permitted The glatiramoid...
Scientific Abstract Listing and Annual Meeting Information - American ...
www.aan.com
David Ladkani, Dalia Nitzani, Zeev. Mazor, Anat Achiron. 4:15 p.m.. S STREAMS: A Phase 2 Clinical Trial of. Autologous Mesenchymal Stem Cells in Active Multiple Sclerosis Rehiana. Ali, Stephen Marley, Renuka. Palanicawandar, Francesco Dazzi,. Richard Nicholas, Paolo Muraro. 4:30 p.m..
Toutes les actualités scientifiques - NeuroScoop - Le site de la ...
www.neuroscoop.net
... TX, Lillian Pardo, Kansas City, KS, Yafit Stark, Smadar Silman, Shaul Kadosh, Batya Zak, Netanya, Israel, David Ladkani, Petah Tiqva, Israel, the PROMiSe Study Group AAN – 56th American Academy of Neurology – San Francisco, 24 avril – 1er mai Retrouvez. SEP et maladies apparentées.
Scientific Publications
Comparing the Biological Impact of Glatiramer Acetate with the...
www.ncbi.nlm.nih.gov
... Bakshi,2 Eran Blaugrund,2 Maxim N. Artyomov,1 Michael R. Hayden,2David Ladkani,2,¶ Rivka Schwartz,2,¶ and Benjamin Zeskind1,¶*.
Publications
Publications Authored by David Ladkani | PubFacts
www.pubfacts.com
Publications Authored by David Ladkani
Laquinimod efficacy in relapsing-remitting multiple sclerosis: how to...
link.springer.com
Background The results of two randomized phase 3 trials that investigated the use of laquinimod in patients with relapsing-remitting multiple sclerosis were...
Miscellaneous
David Ladkani | LinkedIn
www.linkedin.com
View David Ladkani’s professional profile on LinkedIn. LinkedIn is the world's largest business network, helping professionals like David Ladkani discover inside ...
EP A2 - Methods of treating symptoms of multiple ...google.com › patents
patents.google.com
Other languages: German: English: French; Inventor: Aharon Schwartz: David Ladkani: Zeev Mazor: Anat Achiron: Irit Pinchasi: Dina Kofler: Liat Hayardeny ...
US A - Combination of cholecalciferol derivatives for the...
patents.google.com
Mordecai Popovtzer, Ben Z. Weiner, Shmuel Edelstein, Zeev Mazor, David Ladkani, Benjamin Shalita, John A. Kanis: Original Assignee: Teva … Industries Ltd.
US A - Ethoxycarbonyloxy ethyl esters of non-steroidal...
patents.google.com
Novel esters of the general formula ##STR1## in which ##STR2## is the acyl residue of a non-steroidal anti-inflammatory compound containing a carboxylic...
Comparing the Biological Impact of Glatiramer Acetate with the...
journals.plos.org
David Ladkani, Rivka Schwartz, Benjamin Zeskind x. Published: January 8, 2014; DOI: journal.pone ; Article; Authors; Metrics; Comments; Related Content;
zk htm
www.sec.gov
David Ladkani, M.D.. Dr. Ladkani has held roles of increasing responsibility in R&D, business development and medical affairs at senior levels for 32 years at ...
Effect of Alfacalcidol on Fatigue in MS Patients: A Randomized,...
n.neurology.org
David Ladkani 5, Dalia Nitzani 2, ... The effect of treatment on fatigue and quality of life was evaluated using the fatigue impact scale ...
Comparison of physicochemical, biological and genomic.... ECTRIMS...
onlinelibrary.ectrims-congress.eu
Access educational materials, eLearning activities, accredited Live webinar sessions with polls and chat on this fast Digital Library and Hybrid Virtual Event...
DE D1 - Zusammenstellung zur behandlung der osteoporose beim...
patents.google.com
Also published as, CA C, EP A1, EP B1. Publication number, DE D1, DE D1, DE-D , DE , DE D1, DE D1, DE Inventors, Samuel Edelstein, David Ladkani, Shaul Kadosh, Beni Shalita, Ze Ev Mazor, ...
Glatiramer acetate in primary progressive multiple sclerosis: Results...
ucdavis.pure.elsevier.com
Jerry S. Wolinsky, Ponnada A. Narayana, Paul O'Connor, Patricia K. Coyle, Corey Ford, Kenneth Johnson, Aaron Miller, Lillian Pardo, Shaul Kadosh, David Ladkani, Lorne Kastrukoff, Pierre Duquette, Mark Freedman, Marc Debouverie, Catherine Lubetski, Gilles Edan, Etienne Roullet, Christian Confavreux, Alan Thompson ...
E-GEOD < Browse < ArrayExpress < EMBL-EBIwww.ebi.ac.uk › arrayexpress › experiments › E-GEOD
www.ebi.ac.uk
EMBL-EBI
Nucleophilic attacks on carbon–carbon double bonds. Part XVIII....
pubs.rsc.org
Zvi Rappoport and David Ladkani J. Chem. Soc., Perkin Trans. 2, 1973, DOI: P
EP A4 - Method of delaying the onset of clinically definite...
patents.google.com
Inventors, Yafit Stark, David Ladkani. Export Citation, BiBTeX, EndNote, RefMan. Classifications (8), Legal Events (7). External Links: Espacenet, EP Register ...
CA A1 - Method of delaying the onset of clinically definite...
patents.google.com
A method for delaying the onset of clinically definite multiple sclerosis in a patient at risk of developing clinically definite multiple sclerosis and retard...
Most recent papers with the keyword Copaxone | Read by QxMD
read.qxmd.com
Takashi Yamamura, Natalia Ashtamker, David Ladkani, Toshiyuki Fukazawa, Hideki Houzen, Masami Tanaka, Toshiro Miura, Volker Knappertz. OBJECTIVE: Multiple sclerosis (MS) prevalence, clinical patterns, and treatment responses vary between races and geographical latitudes. Glatiramer acetate (GA; Copaxone) ...
Laquinimod efficacy in relapsing-remitting multiple Altmetricspringeropen.altmetric.com › details
springeropen.altmetric.com
Gary R. Cutter, Volker Knappertz, Nissim Sasson, David Ladkani. Abstract. The results of two randomized phase 3 trials that investigated the use of laquinimod ...
Nucleophilic attacks on carbon–carbon double bonds. Part XX. Reaction...
pubs.rsc.org
Nucleophilic attacks on carbon–carbon double bonds. Part XX. Reaction of active methylene compounds with electrophilic olefins. Formation of substituted 2-amino-4-cyano-4H-pyrans. Zvi Rappoport and David Ladkani. J. Chem. Soc., Perkin Trans. 1, 1974, DOI: P PDF · Rich Html.
US B1 - Tricyclic compounds and their uses as antiarrhythmic...
patents.google.com
3, *, Gozlan, Igal; Halpern, Marc; Rabinovitz, Mordecai; Avnir, David; Ladkani, David, IJournal of Heterocyclic Chemistry, 19(6), (English)
Table of Contents — January 01, 2003, 24 (1) | American Journal of...
www.ajnr.org
Table of Contents Volume 24, Issue 1. Editorials. EDITORIAL: ... David Ladkani, Jerry S. Wolinsky, Massimo Filippi, and European/Canadian Glatiramer Acetate Study Group;
Long-term MRI follow-up of patients in the ALLEGRO study ...n.neurology.org › content › 14_Supplement
n.neurology.org
Maria Rocca, Sebastiano Galantucci, Yuval Dadon, Tali Gorfine, David Ladkani, Nissim Sasson, Giancarlo Comi, Massimo Filippi.
Related search requests for David Ladkani
| Benjamin Shalita Dina Kofler Massimo Filippi | Nissim Sasson Liat Hayardeny Volker Knappertz | Zeev Mazor Giancarlo Comi Marco Rovaris |
People Forename "David" (200146) Name "Ladkani" (13) |
sorted by relevance / date